Chronic activation of the immune system is a hallmark of progressive HIV infection and better
predicts disease outcome than plasma viral load, yet its etiology remains obscure. Here we …

The success of antiretroviral therapy has led some people to now ask whether the end of
AIDS is possible. For patients who are motivated to take therapy and who have access to …

Background The optimal time for the initiation of antiretroviral therapy for asymptomatic patients
with human immunodeficiency virus (HIV) infection is uncertain. Methods We conducted …

Although antiretroviral therapy for HIV infection prevents AIDS-related complications and
prolongs life, it does not fully restore health. Long-term treated patients remain at higher than …

Background . Chronic human immunodeficiency virus (HIV) infection is associated with intestinal
permeability and microbial translocation that contributes to systemic immune activation, …

Although T cell activation is associated with disease progression in untreated human
immunodeficiency virus type 1 (HIV-1) infection, its significance in antiretroviral-treated patients is …

Although generalized T-cell activation is an important factor in chronic HIV disease pathogenesis,
its role in primary infection remains poorly defined. To investigate the effect of immune …

Objective. —The clinical care of people infected with human immunodeficiency virus (HIV)
has been substantially affected by the introduction of HIV-specific protease inhibitors (Pis). …

Allotypes of the natural killer (NK) cell receptor KIR3DL1 vary in both NK cell expression
patterns and inhibitory capacity upon binding to their ligands, HLA-B Bw4 molecules, present on …

Chronic viral infections can appear in two very different forms: those that are typically
immunologically contained after acute symptomatic infection, such as Epstein-Barr virus (EBV), and …